SIGNIFICANCE OF DETERMINATION OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
Abstract
Introduction: Lipoprotein-associated Phospholipase A2 (LP-PLA2) is an essential mediator of inflammation, which has a vital role in inflammatory diseases of the vascular system. It has a significant role in the occurrence of thrombosis, the main manifestation of antiphospholipid syndrome.
The Aim: To investigate the values of Lp-PLA2 in patients with antiphospholipid syndrome (APS) regarding the distribution of all data, age, gender, disease duration, and type of disease.
Material and Methods: This experimental work analysed samples of 74 patients diagnosed with APS. Concentrations of Lp-PLA2 were determined by ELISA (Enzyme-Linked Immunosorbent Assay) method.
Results: The activity of Lp-PLA2 was higher than recommended referent values. There is no significant difference in the values of Lp-PLA2 concerning patientsʼ age, gender, disease duration, and type of the disease (P > 0,05). There was a statistically significant correlation between the patientsʼ age and the disease duration (rho = 0,359; P = 0,002).
Conclusion: Elevated values of Lp-PLA2, so as the correlation between the years of age and duration of APS can be important information to doctors in the appropriate management of these patients. It is up to future prospective studies to confirm the significance of Lp-PLA2 determination in patients with APS.
References
- Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun. 2017 Jan; (76):10-20.
- Đoković A, Stojanović Lj. Kardiološke manifestacije u antifosfolipidnom sindromu – pregled literature. Srpski arhiv za celokupno lekarstvo. 2015; 134(5-6):346-353.
- Đukić S, Anđelković N, Đurđević P, Sretenović S, Necin-Jovanović Z, Đukić A, et al. Antifosfolipidni sindrom: Kliničko stanje koje se nedovoljno često prepoznaje. Medical journal. 2008; 1:48-56.
- Bećarević M, Majkić Singh N. Potencijalni pokazatelji arterijskih i/ili venskih tromboza i njihovih komplikacija u primarnom antifosfolipidnom sindromu. JMB. 2007; 26(4):259-268.
- Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010 Oct; 376(9751):1498-1509.
- Nezos A, Skarlis C, Psarrou A, Markakis K, Garantziotis P, Papanikolaou A, et al. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in SjÖgren’s Syndrome-Related Lymphoma. Front Immunol. 2021 Jun; 12:683623.
- Lerman A, McConnell J Lipoprotein-Associated Phospholipase A2: A Risk Marker or a Risk Factor. Am J Cardiol. 2008 Jun; 101(12A):11F-22F.
- Bargieł W, Cierpiszewska K, Maruszczak K, Pakuła A, Szwankowska D, Wrzesińska A, et al. Recognized and Potentially New Biomarkers-Their Role in Diagnosis and Prognosis of Cardiovaskular Disease. Medicina. 2021 Jul; 57(7):
- Huang F, Wang K, Shen J. Lipoprotein-associated phospholipase A2: The story continues. Med Res Rev. 2020 Jan;40(1):79-134.
- Nikolaou A, Kokotou MG, Vasilakaki S, Kokotos G. Small–molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipase A2. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun; 1864(6):941-956.
- Vittos O, Toana B, Vittos A, Moldoveanu E. Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker. Biomarkers. 2012 Jun; 17(4):289-302.
- Cervera R. Antiphospholipid syndrome. Thromb Res. 2017 Mar; 151:S43-S47.
- Li D, Wei W, Ran X, Yu J, Li H, Zhao L, et al. Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis. Clin Chim Acta. 2017 Aug; 471:38-45.
- De Stefano A, Mannucci L, Massoud R, Bernardini S, Cortese C. Performance characteristics of lipoprotein-associated phospholipase A2 activity assay on the Dimension Vista analyser and preliminary study of a healthy Italian population. Biochem Med. 2017 Oct; 27(3):030701.
- Feng LM, Feng GF, Chen Y. Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum. Lipids Health Dis. 2014 Jan; 13(1):6.
- Green D. Pathophysiology of Antiphospholipid Syndrome. Thromb Haemost. 2021 Nov; DOI: 10.1055/a-1701-2809.
- Fabris M, CifÙ A, Pistis C, Siega-Ducaton M, Fontana DE, Giacomello R, et al. Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies. Auto Immun Highlights. 2017 Dec; 8(1):5.
- Trotter A, Anstadt E, Clark R, Nichols F, Dwivedi A, Aung K, et al. The Role of Phospholipase A2 in Multiple Sclerosis. A Systematic Review and Meta-analysis. Mult Scler Relat Disord. 2018 Jan; 27:206-213.